Jordan Manek Chinai, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunoglobulins | 5 | 2021 | 859 | 0.550 |
Why?
|
Virus Diseases | 1 | 2015 | 720 | 0.330 |
Why?
|
Imidazoles | 1 | 2011 | 1180 | 0.240 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2016 | 1088 | 0.220 |
Why?
|
Immunotherapy | 3 | 2016 | 4642 | 0.220 |
Why?
|
Antiviral Agents | 1 | 2015 | 3061 | 0.210 |
Why?
|
Receptors, KIR | 1 | 2021 | 113 | 0.190 |
Why?
|
Antibodies, Monoclonal | 4 | 2021 | 9185 | 0.180 |
Why?
|
Osteosarcoma | 2 | 2016 | 897 | 0.180 |
Why?
|
Insulin | 1 | 2011 | 6597 | 0.130 |
Why?
|
Genes, erbB-1 | 1 | 2016 | 160 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2021 | 4550 | 0.110 |
Why?
|
Neoplasms | 3 | 2021 | 22072 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13630 | 0.100 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2011 | 72 | 0.100 |
Why?
|
Hybridomas | 1 | 2011 | 442 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 967 | 0.080 |
Why?
|
Phenylalanine | 1 | 2011 | 365 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2011 | 1792 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6216 | 0.070 |
Why?
|
Tumor Microenvironment | 2 | 2016 | 3844 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2016 | 2725 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1407 | 0.060 |
Why?
|
Models, Molecular | 2 | 2014 | 5434 | 0.060 |
Why?
|
Killer Cells, Natural | 3 | 2021 | 2203 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3610 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2532 | 0.060 |
Why?
|
Protein Conformation | 1 | 2011 | 3969 | 0.050 |
Why?
|
Protein Binding | 2 | 2014 | 9335 | 0.050 |
Why?
|
3T3 Cells | 2 | 2014 | 1085 | 0.050 |
Why?
|
Binding Sites | 1 | 2011 | 6048 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4353 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6315 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5251 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2016 | 2943 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16939 | 0.040 |
Why?
|
Cell Survival | 2 | 2021 | 5797 | 0.040 |
Why?
|
Carcinoma, Large Cell | 1 | 2016 | 113 | 0.030 |
Why?
|
Animals | 6 | 2021 | 167963 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 401 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 551 | 0.030 |
Why?
|
Surface Plasmon Resonance | 1 | 2014 | 265 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2014 | 297 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5130 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 303 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13451 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2021 | 2299 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 18957 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13262 | 0.020 |
Why?
|
Glycosylation | 1 | 2014 | 1096 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17624 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2013 | 835 | 0.020 |
Why?
|
Humans | 10 | 2021 | 760621 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2014 | 1982 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2013 | 2753 | 0.020 |
Why?
|
Mice | 4 | 2021 | 81208 | 0.020 |
Why?
|
Cytoplasm | 1 | 2013 | 1516 | 0.020 |
Why?
|
Epitopes | 1 | 2014 | 2503 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3800 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1972 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1974 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1135 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1827 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2013 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6828 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6544 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 29658 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2298 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2209 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2013 | 1885 | 0.010 |
Why?
|
Cell Membrane | 1 | 2013 | 3682 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5870 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4264 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7588 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10182 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5745 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4024 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9411 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8515 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4742 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10446 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7343 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10181 | 0.010 |
Why?
|
Female | 4 | 2016 | 391270 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9501 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18137 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29932 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 220352 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58741 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21025 | 0.000 |
Why?
|
Male | 2 | 2016 | 359744 | 0.000 |
Why?
|
Child | 1 | 2016 | 79806 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 87810 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2016 | 80372 | 0.000 |
Why?
|
Aged | 1 | 2016 | 169152 | 0.000 |
Why?
|
Adult | 1 | 2016 | 219994 | 0.000 |
Why?
|